Healthcare Management Alnylam Presents New Results from the ILLUMINATE-C Phase 3 Study of Lumasiran in Patients with… AIT News Desk May 25, 2022 – Lumasiran Demonstrated Evidence of Improvements in Exploratory Endpoints of Systemic Oxalosis, Including Echocardiographic Structure and…